Atlas Trials

Using Calcium Dobesilate to Treat Chinese Patients With Mild to Moderate Non-proliferative Diabetic Retinopathy

Clinical trial NCT04283162 · UNKNOWN

Trial details

NCT number
NCT04283162
Sponsor
Zhongda Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Retinopathy
Start date
2020-03-01
Primary completion
2021-12-31
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.